With November marking Lung Cancer Awareness Month, medical experts are urging eligible residents to get screened before ...
Bio-Rad adds new ddPCR assays, reagents and technologies for QX700 systems, expanding multiplex cancer mutation and biomarker ...
Women who have undergone a double mastectomy to treat ductal carcinoma in situ (DCIS), a noninvasive form of breast cancer ...
At 67 years old, Cindy Brill was not expecting her health to change, but after experiencing unexplained vaginal bleeding, she ...
CHOSA Oncology AB announces that it has entered into an agreement with a CLIA-certified laboratory to develop and validate ...
Tech Times on MSN
RAD101 wins FDA phase 3 alignment: FASN-targeted PET scan aims to end brain MRI ambiguity
RAD101 PET scan brain metastases diagnosis reached a pivotal milestone as Radiopharm Theranostics secured FDA alignment on a ...
AI assistance raised prostate biopsy diagnostic accuracy among pathology residents, with the largest gains among less ...
“A mole on my body—could it be a warning sign?” ... Symptoms that may point to melanoma, a deadly skin cancer ...
The Rota resident thought he had left the habit behind for good when he quit cold turkey in 2013. But in 2025, what initially ...
BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results ...
Rutika Mehta, MD, MPH, discussed biomarker testing, PD-L1–low treatment, FLOT dosing, early referral, and ctDNA in ...
Plus, who is eligible?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results